Centaurus Financial, Inc. Edwards Lifesciences Corp Transaction History

Centaurus Financial, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Sep 20, 2024	BUY	$84.3 - $94.31 $17,871 - $19,993	212 Added 13.17%	1,822 $168,000
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $10,808 - $14,238	-149 Reduced 8.47%	1,610 $153,000
Q4 2023 Feb 26, 2024	SELL	$61.71 - $77.76 $16,723 - $21,072	-271 Reduced 13.35%	1,759 $134,000
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $46,625 - $62,844	673 Added 49.59%	2,030 $141,000
Q2 2023 Aug 15, 2023	SELL	$81.41 - $94.33 $155,900 - $180,641	-1,915 Reduced 58.53%	1,357 $128,000
Q1 2023 May 17, 2023	BUY	$74.26 - $84.51 $59,185 - $67,354	797 Added 32.2%	3,272 $271,000
Q4 2022 Feb 10, 2023	SELL	$68.3 - $87.44 $8,605 - $11,017	-126 Reduced 4.84%	2,475 $184,000
Q3 2022 Dec 05, 2022	BUY	$82.37 - $107.29 $14,579 - $18,990	177 Added 7.3%	2,601 $215,000
Q2 2022 Aug 02, 2022	BUY	$86.5 - $128.27 $209,676 - $310,926	2,424 New	2,424 $230,000
Q3 2018 Nov 05, 2018	SELL	$45.7 - $58.03 $35,828 - $45,495	-784 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$42.45 - $51.3 $33,280 - $40,219	784 New	784 $114,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Centaurus Financial, Inc. with notifications on news.